Drug intelligence / Profile preview

Eleutherococcus fluid extract

Development stage
Unknown
Lead developer
Dalkhimpharm
Modality
Small Molecules
Administration
Oral
01

Overview

Eleutherococcus fluid extract is a traditional herbal medicine produced by OJSC Dalkhimpharm, derived from the roots and rhizomes of *Eleutherococcus senticosus* (Siberian ginseng). It is prepared as a 1:1 fluid extract using 40% ethanol as the solvent. Classified as an adaptogen and tonic agent (ATC code A13A), the extract contains a complex mixture of active phytochemicals, most notably eleutherosides (glycosides A-M), phenolic compounds, and polysaccharides. The medicine is primarily indicated for the treatment of asthenia, fatigue, and decreased physical or mental performance. It works by enhancing the body's non-specific resistance to various stressors and adverse environmental factors, a property characteristic of adaptogenic substances. This product has been industrially produced in Russia since 1964 and remains a staple of the regional pharmacopeia.

Brand names
Eleutherococcus fluid extract
Other names
Siberian ginseng extractEleutherococcus senticosus extractExtractum Eleutherococci fluidum
02

Targets

PR (Progesterone receptor)MR (Mineralocorticoid receptor)ER (Estrogen receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Eleutherococcus fluid extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eleutherococcus fluid extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call